Drugs / CN54gp140 glycoprotein-hsp70 conjugate vaccine
CN54gp140 glycoprotein-hsp70 conjugate vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01285141 | Jul 2011 → Jan 2012 | HIV infectious disease | St George's, University of London | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CN54gp140 glycoprotein-hsp70 conjugate vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01285141 ↗ |
| Modality | Vaccine | “The aim of this vaccine trial in women was to administer by the vaginal mucosal route a vaccine consisting of HIV-1 gp140 linked to the chaperone 70-kDa heat shock protein (HSP70).” PMID 25008917 ↗ Jul 2014 |
| Route | Other | “administered intravaginally” NCT01285141 ↗ |